Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002023072 | SCV002305837 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002548213 | SCV003736525 | uncertain significance | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.397A>T (p.R133W) alteration is located in exon 1 (coding exon 1) of the PPCS gene. This alteration results from a A to T substitution at nucleotide position 397, causing the arginine (R) at amino acid position 133 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV002023072 | SCV005411796 | uncertain significance | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | BP4 |